Publication | Open Access
Alpha-l-fucosidase: a novel serum biomarker to predict prognosis in early stage esophageal squamous cell carcinoma
16
Citations
21
References
2019
Year
Compared with other serum biomarkers, AFU showed a better prognostic value for long-term survival in patients with early stage ESCC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1